Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors

Published:2015-06-19 Issue:S40 Volume:50 Page:S3-S13
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol.

Author:

Solomon George M.¹,Marshall Susan G.²,Ramsey Bonnie W.²³,Rowe Steven M.¹⁴

Affiliation:

1. Department of Medicine and the Gregory Fleming James Cystic Fibrosis Research Center; Birmingham Alabama

2. Division of Pulmonary Medicine, Department of Pediatrics; University of Washington School of Medicine; Seattle Washington

3. Center for Clinical and Translational Research; Seattle Children's Research Institute; Seattle Washington

4. Departments of Medicine, Pediatrics, Cell Developmental and Integrative Biology; University of Alabama at Birmingham; Birmingham Alabama

Funder

GS

SR

BR

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ppul.23240/fullpdf

Reference85 articles.

1. Identification of the cystic fibrosis gene: genetic analysis;Kerem;Science,1989

2. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA;Riordan;Science,1989

3. Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel;Berger;J Clin Invest,1991

4. The ABC protein turned chloride channel whose failure causes cystic fibrosis;Gadsby;Nature,2006

5. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease;Matsui;Cell,1998

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle-based platforms for targeted drug delivery to the pulmonary system as therapeutics to curb cystic fibrosis: A review;Journal of Microbiological Methods;2024-02

2. Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome;Expert Opinion on Investigational Drugs;2023-08-03

3. Cystin is required for maintaining fibrocystin (FPC) levels and safeguarding proteome integrity in mouse renal epithelial cells;The FASEB Journal;2023-06-15

4. Genome Editing for Cystic Fibrosis;Cells;2023-06-06

5. Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosis;Journal of Managed Care & Specialty Pharmacy;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3